Anti-PCSK9 Antibody (Tafolecimab)
Catalog No.
F1459
Anti-PCSK9 Antibody (Tafolecimab)
Featured Products
Tafolecimab (IBI-306) is a humanized IgG2 monoclonal antibody that specifically bindsPCSK-9 It also reduces LDL-C levels by inhibiting PCSK-9-mediated endocytosis of low-density lipoprotein receptors, thereby enhancing the clearance of LDL-C, leading to lower LDL-C levels. Tafolecimab can be used in the study of hypercholesterolemia.
145.34 kDa
Dry ice
2225109-03-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
IBI-306
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q8NBP7
Human
Unconjugated
Monoclonal
IgG2SA
ELISA, FACS, Kinetics, Functional assay, Animal Model
PCSK9
Please avoid freeze-thaw cycles.